SHS Gesellschaft für Beteiligungsmanagement mbH

Investing in Fast growing Companies

We call ourselves Growth Buyout investors, which summarizes the strategy of SHS to invest in both – buyout transactions in established companies as well as growth investments in scale-up companies in the healthcare field.

More about Private Equity More about Growth Financing
Home Our Investment Strategy
SHS Capital · Explore our investment approach
02 / 03
‹‹‹
Previous
›››
Next
Tübingen · Germany
48.52° N · 9.06° E
Mission · Tübingen

We back healthcare companies with the ambition to become European champions.

Based in Tübingen, one of Germany’s recognised healthcare and life-sciences hubs, SHS has invested in innovative healthcare companies since 1993.

We combine capital with more than three decades of sector experience, a specialist network and expertise across market access, reimbursement, commercialisation, M&A and exit.

1993 Founded in Tübingen
30+ years Healthcare experience
Healthcare only Specialist investment focus
Healthcare · Private Equity
Established · Growing
Private Equity

We invest in established healthcare companies built to lead in fast-developing markets.

As Germany’s leading investor for healthcare companies, we bring not only capital, but also strategic expertise and synergies from across our portfolio into each partnership.

SHS Capital’s value proposition is further strengthened by an extensive healthcare network built over more than 30 years — spanning leading KOLs, experienced operators and seasoned industry leaders.

Established & growing Company profile
Healthcare Sector focus
30+ years Specialist network
Healthcare · Growth Financing
Commercialization · Expansion
Growth Financing

We back healthcare innovators ready to turn technology into scalable growth.

Our growth investments focus on companies that have started the commercialization of their cutting-edge technologies and are ready for their next phase of development.

Beyond capital, we provide our network and specialist expertise across approval and reimbursement in the USA and China, organizational development, marketing and sales, M&A and exit.

Commercialization Investment stage
Healthcare Sector focus
Scaling & expansion Value creation

Opportunities for Private Equity

Succession

Ensuring sustainable growth.

As an investor with experience in the sector, SHS has already successfully implemented a large number of company successions for healthcare companies.

International expansion

Opening up new markets often goes hand in hand with high capital requirements.

SHS has already supported many medium-sized companies with capital and expertise in order to implement their plans to expand into the USA or Asia.

Minority shareholdings

Combining strengths: SHS is interested in minority shareholdings.

We help owners in getting their company to the next level by adding complementary teams from our network or helping to improve internal processes, setting up direct sales teams or scaling up manufacturing.

We bring into a partnership

01 Long-term view on value-enhancing measures of company building and value creation
02 Many years of expertise in the analysis and implementation of growth strategies
03 Business development support through our extensive network of KOLs, industry contacts and leading scientists
SHS Capital · Explore our investment approach
03 / 03
‹ ‹ ‹
Previous
› › ›
Next
Tübingen · Germany
48.52° N · 9.06° E
Mission · Tübingen

We back healthcare companies with the ambition to become European champions.

Based in Tübingen, one of Germany’s recognised healthcare and life-sciences hubs, SHS has invested in innovative healthcare companies since 1993.

We combine capital with more than three decades of sector experience, a specialist network and expertise across market access, reimbursement, commercialisation, M&A and exit.

1993 Founded in Tübingen
30+ years Healthcare experience
Healthcare only Specialist investment focus
Healthcare · Private Equity
Established · Growing
Private Equity

We invest in established healthcare companies built to lead in fast-developing markets.

As Germany’s leading investor for healthcare companies, we bring not only capital, but also strategic expertise and synergies from across our portfolio into each partnership.

SHS Capital’s value proposition is further strengthened by an extensive healthcare network built over more than 30 years — spanning leading KOLs, experienced operators and seasoned industry leaders.

Established & growing Company profile
Healthcare Sector focus
30+ years Specialist network
Healthcare · Growth Financing
Commercialization · Expansion
Growth Financing

We back healthcare innovators ready to turn technology into scalable growth.

Our growth investments focus on companies that have started the commercialization of their cutting-edge technologies and are ready for their next phase of development.

Beyond capital, we provide our network and specialist expertise across approval and reimbursement in the USA and China, organizational development, marketing and sales, M&A and exit.

Commercialization Investment stage
Healthcare Sector focus
Scaling & expansion Value creation

Growth capital
possibilities

Financing rollout

We drive the national and European market launch of your product.

Our portfolio companies benefit from our long-standing relationships with the leading players in the healthcare sector in Europe, such as corporates, hospitals and insurance companies.

Financing FDA approval

Entering the attractive US market can be challenging.


Thanks to our many years of experience, working together can prevent time-consuming loops in the approval process.

Financing clinical studies

Clinical validation is essential for the highly competitive healthcare market.

In addition to capital, our portfolio companies benefit from our contacts to the leading study centers and consultants in Europe.

We bring into a partnership

01 A long-standing network of leading KOLs and industry experts in the healthcare sector.
02 Cooperation with health insurance companies and the leading healthcare corporates
03 Expertise in sector-specific topics such as IP, regulation and reimbursement